Long read sequencing for Clinical diagnostics is rapidly evolving and provides insights into genetic variations like structural variations, CNVs and methylation in hard to sequence regions using conventional short read technologies. Unambiguous mapping of long-read couple with solutions that enable targeted capture without the need for PCR opens up the possibility to exploit it to transform health care genomics. A whole range of products cater to different scales and needs of diagnostic labs to handle few hundred to several thousand Human genomes or targeted sequencing.
A rapid, low-cost, highly scalable diagnostic test for SARS CoV-2. LamPORE assay is designed in such a way that it can be deployed in high-throughput traditional lab set-up and local setting as well.
We can create LamPORE assay for multiple disease like Zika, Ebola etc.,
